Import/Export Licensing refers to the official permissions required to bring goods into a country (import) or send goods out of a country (export). These licenses are legal documents issued by government authorities to regulate the movement of specific products across international borders.
The licensing process ensures compliance with trade regulations, safety standards, and national security measures. It may involve submitting applications, paying fees, and meeting certain criteria before engaging in international trade activities for controlled or restricted items.
Import/Export Licensing is crucial in clinical research as it ensures the legal and controlled movement of investigational drugs, biological samples, and specialized equipment across international borders. These licenses help maintain regulatory compliance, protect patient safety, and preserve the integrity of clinical trials conducted in multiple countries.
Proper licensing facilitates seamless collaboration between research institutions, sponsors, and contract research organizations (CROs) operating globally. It also enables researchers to access vital resources and technologies from different parts of the world, potentially accelerating drug development and improving the overall efficiency of clinical studies.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant